%PDF-1.4
1 0 obj
<<
/Type /Catalog
/Pages 2 0 R
>>
endobj

2 0 obj
<<
/Type /Pages
/Kids [3 0 R]
/Count 1
>>
endobj

3 0 obj
<<
/Type /Page
/Parent 2 0 R
/MediaBox [0 0 612 792]
/Contents 4 0 R
/Resources <<
/Font <<
/F1 5 0 R
/F2 6 0 R
/F3 7 0 R
>>
>>
>>
endobj

4 0 obj
<<
/Length 2000
>>
stream
BT
/F1 16 Tf
50 750 Td
(UROLOGY CONSULTATION NOTES - DAVID BROWN) Tj
0 -30 Td
/F2 10 Tf
(Visit Date: 12/25/2024 | Provider: Dr. Christopher Lee, MD - Urology) Tj
0 -30 Td
/F1 14 Tf
(CONSULTATION REQUEST) Tj
0 -20 Td
/F2 10 Tf
(Referring Physician: Dr. Carlos Garcia, MD - Primary Care) Tj
0 -15 Td
(Reason for Consultation: Elevated PSA and prostate cancer diagnosis) Tj
0 -15 Td
(Urgency: Routine consultation) Tj
0 -15 Td
(Clinical Question: Treatment options for localized prostate cancer) Tj
0 -30 Td
/F1 14 Tf
(HISTORY OF PRESENT ILLNESS) Tj
0 -20 Td
/F2 10 Tf
(56-year-old male with elevated PSA level of 8.5 ng/mL discovered) Tj
0 -15 Td
(during routine screening. Digital rectal examination revealed) Tj
0 -12 Td
(a firm nodule in the right lobe of the prostate. Prostate biopsy) Tj
0 -12 Td
(confirmed adenocarcinoma with Gleason score 7 (3+4). Patient) Tj
0 -12 Td
(has been on active surveillance for 6 months with stable disease.) Tj
0 -12 Td
(No symptoms of urinary obstruction, no bone pain, no weight loss.) Tj
0 -12 Td
(Patient is 56 years old with excellent functional status and) Tj
0 -12 Td
(desires definitive treatment. Family history of prostate cancer) Tj
0 -12 Td
((father diagnosed at age 65).) Tj
0 -30 Td
/F1 14 Tf
(PROSTATE CANCER STAGING) Tj
0 -20 Td
/F2 10 Tf
(Clinical Stage: T1c (nonpalpable, PSA-detected)) Tj
0 -15 Td
(Gleason Score: 7 (3+4)) Tj
0 -15 Td
(PSA Level: 8.5 ng/mL) Tj
0 -15 Td
(Percentage of Cancer: 25% of biopsy cores) Tj
0 -15 Td
(Perineural Invasion: Not identified) Tj
0 -15 Td
(Lymphovascular Invasion: Not identified) Tj
0 -15 Td
(Risk Category: Intermediate risk) Tj
0 -30 Td
/F1 14 Tf
(TREATMENT OPTIONS DISCUSSED) Tj
0 -20 Td
/F2 10 Tf
(1. Active Surveillance:) Tj
0 -15 Td
(   - Continue monitoring with PSA and repeat biopsies) Tj
0 -15 Td
(   - Risk of disease progression over time) Tj
0 -15 Td
(   - Patient declined due to family history) Tj
0 -20 Td
(2. Radical Prostatectomy:) Tj
0 -15 Td
(   - Open vs. robotic approach) Tj
0 -15 Td
(   - Nerve-sparing technique if possible) Tj
0 -15 Td
(   - Patient prefers robotic approach) Tj
0 -20 Td
(3. Radiation Therapy:) Tj
0 -15 Td
(   - External beam radiation vs. brachytherapy) Tj
0 -15 Td
(   - Patient prefers surgical option) Tj
0 -30 Td
/F1 14 Tf
(ASSESSMENT AND PLAN) Tj
0 -20 Td
/F2 10 Tf
(1. PROSTATE CANCER - Localized (Gleason 7, PSA 8.5)) Tj
0 -15 Td
(   Plan: Robotic radical prostatectomy for definitive treatment) Tj
0 -15 Td
(   Consider nerve-sparing technique if possible) Tj
0 -20 Td
(2. HYPERTENSION - Well controlled) Tj
0 -15 Td
(   Plan: Continue current medication, monitor BP) Tj
0 -20 Td
(3. HYPERLIPIDEMIA - Continue statin therapy) Tj
0 -15 Td
(   Plan: Continue atorvastatin, recheck lipids in 6 months) Tj
0 -20 Td
(4. BENIGN PROSTATIC HYPERPLASIA - Mild, continue current management) Tj
0 -15 Td
(   Plan: Continue tamsulosin, consider discontinuation post-surgery) Tj
0 -30 Td
/F1 14 Tf
(PRIOR AUTHORIZATION REQUEST) Tj
0 -20 Td
/F2 10 Tf
(Service Requested: Robotic Prostatectomy) Tj
0 -15 Td
(CPT Code: 55866) Tj
0 -15 Td
(ICD-10 Code: C61 - Malignant neoplasm of prostate) Tj
0 -15 Td
(Medical Necessity: Patient presents with localized prostate cancer) Tj
0 -12 Td
((Gleason score 7). PSA level is 8.5 ng/mL. Digital rectal) Tj
0 -12 Td
(examination reveals a firm nodule in the right lobe. Prostate) Tj
0 -12 Td
(biopsy confirmed adenocarcinoma. Robotic prostatectomy is) Tj
0 -12 Td
(medically necessary for definitive treatment of localized) Tj
0 -12 Td
(prostate cancer. Clinical guidelines support surgical intervention) Tj
0 -12 Td
(for patients with localized disease and good performance status.) Tj
0 -12 Td
(Patient is 56 years old with excellent functional status.) Tj
0 -30 Td
/F3 8 Tf
(Provider: Dr. Christopher Lee, MD - Urology | Date: 12/25/2024 | E-Signature: Applied) Tj
0 -15 Td
(Notes ID: U20241225005 | Timestamp: 12/25/2024 09:15:30) Tj
ET
endstream
endobj

5 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica-Bold
>>
endobj

6 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica
>>
endobj

7 0 obj
<<
/Type /Font
/Subtype /Type1
/BaseFont /Helvetica-Oblique
>>
endobj

xref
0 8
0000000000 65535 f 
0000000009 00000 n 
0000000058 00000 n 
0000000115 00000 n 
0000000274 00000 n 
0000002274 00000 n 
0000002524 00000 n 
0000002774 00000 n 
trailer
<<
/Size 8
/Root 1 0 R
>>
startxref
2875
%%EOF
